Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-15

Clinical Trial Update: Trental for the Treatment of Vertigo/Dizziness/Imbalance [NA]

View source ↗

Summary

A University of Missouri-Columbia sponsored trial evaluating Trental (pentoxifylline) for dizziness and vertigo was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trental (pentoxifylline)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Dizziness, Vertigo | NA | Status: TERMINATED | Results posted: 2024-10-15